2m 2m 2m 2m 2m 2m 2m
RENOVORX (RNXT)
NASDAQ
$1.57-$0.01 (-0.89%)
Price as of Oct 02, 2026 7:00 PM EDT- $70.0MMarket Cap
- 19.70%1-Year Change
- BiotechnologyIndustry
RENOVORX (RNXT)
$1.57-$0.01 (-0.89%)
RNXT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.58 | ||
Change | +$0.03 (+1.94%) | ||
Open | $1.57 | ||
High | $1.61 | ||
Low | $1.55 | ||
Previous Close | $1.55 | ||
Volume | 269,370 | ||
30-Day Average Volume | 1,123,715 | ||
1-Week Change | -4.82% | ||
1-Month Change | -37.30% | ||
1-Year Change | 19.70% | ||
3-Year Change | 42.99% | ||
5-Year Change | -73.27% | ||
Fundamentals | |||
Shares Outstanding | 45.1M | ||
Total Assets | $11.5M | ||
Market Cap | $70.0M | ||
Enterprise Value | $60.5M | ||
Period: QTR TTM FY | |||
Revenue | $909,000.00 | ||
Net Income | -$2.9M | ||
Free Cash Flow | -$2.9M | ||
EBIT | -$2.9M | ||
EBITDA | -$2.9M | ||
Net Working Capital | $8.9M | ||
EPS | -$0.06 | ||
Enterprise Value/EBITDA | -21 | ||
Enterprise Value/Revenue | 67 | ||
P/B | 8 | ||
P/E | -26 | ||
PEG | -1 | ||
Price/Free Cash Flow | -24 | ||
Price/Operating Cash Flow | -24 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue